KAPA Q1 2026 Earnings EPS Misses Estimates as Development Expenses Weigh VUZI Q1 2026 Earnings Narrowed Loss Surprises Revenue Remains Absent ELDN Q1 2026 Earnings ClinicalStage Biotech Misses EPS Estimates Amid Ongoing Development Costs REKR Q1 2026 Earnings EPS Misses Estimates Revenue Data Unavailable ISBA Q1 2026 Earnings Earnings Per Share Falls Well Short of Expectations CHTR Q1 2026 Earnings EPS Misses Estimates as Broadband Subscriber Trends Pressure Results